Direktorat Registrasi ObatValid

MOMETASONE FUROATE

BPOM Number: GKL2617635829A1
Approved: 5 May 2026
Expiry: 20 April 2031
Form: Cream

About This Registration

MOMETASONE FUROATE is a BPOM-registered direktorat registrasi obat in Indonesia, registered under number GKL2617635829A1. Its current registration status is Valid, with the licence valid until 20 April 2031. The product is registered to INTERBAT - INDONESIA. BPOM first approved this registration in April 2026. All registration data is sourced directly from the official BPOM public database and updated daily.

Registration Details

Application: newaero
Packaging: DUS, 1 TUBE @ 10 GRAM
Department: Direktorat Registrasi Obat

Retail Audit Service

Get detailed market intelligence for this product across Indonesian retail channels

Multiple cities available

Custom questionnaires

Professional shoppers

Detailed reporting

Starting from $50 per city

What's included in the audit service?

Stock availability and positioning verification

Price checking and competitor analysis

Display quality and promotional material assessment

Store condition and customer experience evaluation

Custom questions tailored to your research needs

Professional photographs and detailed reports

Registered Owners

INTERBAT - INDONESIA
KAB. SIDOARJO
NPWP: 010019172073000
owner
View profile →

Manufacturing Sites

INTERBAT - INDONESIA
KAB. SIDOARJO
primary
View profile →

Ingredients (1)

MOMETASONE FUROATE

Market Intelligence

Owner Portfolio: INTERBAT - INDONESIA holds 329 BPOM registrations
Manufacturer Scale: INTERBAT - INDONESIA produces 329 registered products
Registration Age: Registered for 2 months
Update Status: Recently updated (73 days ago)

FDA Cross-Reference

via openFDA

Generic Name: MOMETASONE FUROATE
Product Type: HUMAN PRESCRIPTION DRUG
Route of Administration: TOPICAL

Data sourced from the U.S. FDA drug label database (openFDA). May not exactly match this product variant.

Is this your product?